These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 23555165)

  • 1. Psychosocial factors and their association with reflux oesophagitis, Barrett's oesophagus and oesophageal adenocarcinoma.
    Denver P; Donnelly M; Murray LJ; Anderson LA
    World J Gastroenterol; 2013 Mar; 19(11):1770-7. PubMed ID: 23555165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dietary magnesium, calcium:magnesium ratio and risk of reflux oesophagitis, Barrett's oesophagus and oesophageal adenocarcinoma: a population-based case-control study.
    Dai Q; Cantwell MM; Murray LJ; Zheng W; Anderson LA; Coleman HG;
    Br J Nutr; 2016 Jan; 115(2):342-50. PubMed ID: 26563986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dietary inflammatory index and risk of reflux oesophagitis, Barrett's oesophagus and oesophageal adenocarcinoma: a population-based case-control study.
    Shivappa N; Hebert JR; Anderson LA; Shrubsole MJ; Murray LJ; Getty LB; Coleman HG
    Br J Nutr; 2017 May; 117(9):1323-1331. PubMed ID: 28571591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of Barrett's oesophagus, oesophageal adenocarcinoma and reflux oesophagitis and the use of nitrates and asthma medications.
    Ladanchuk TC; Johnston BT; Murray LJ; Anderson LA;
    Scand J Gastroenterol; 2010 Dec; 45(12):1397-403. PubMed ID: 20626305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The association between alcohol and reflux esophagitis, Barrett's esophagus, and esophageal adenocarcinoma.
    Anderson LA; Cantwell MM; Watson RG; Johnston BT; Murphy SJ; Ferguson HR; McGuigan J; Comber H; Reynolds JV; Murray LJ
    Gastroenterology; 2009 Mar; 136(3):799-805. PubMed ID: 19162028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adam, Eve and the reflux enigma: age and sex differences across the gastro-oesophageal reflux spectrum.
    Royston C; Bardhan KD
    Eur J Gastroenterol Hepatol; 2017 Jun; 29(6):634-639. PubMed ID: 28151751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycemic index, carbohydrate and fiber intakes and risk of reflux esophagitis, Barrett's esophagus, and esophageal adenocarcinoma.
    Mulholland HG; Cantwell MM; Anderson LA; Johnston BT; Watson RG; Murphy SJ; Ferguson HR; McGuigan J; Reynolds JV; Comber H; Murray LJ
    Cancer Causes Control; 2009 Apr; 20(3):279-88. PubMed ID: 18839322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acid suppression medications reduce risk of oesophageal adenocarcinoma in Barrett's oesophagus: a nested case-control study in US male veterans.
    Tan MC; El-Serag HB; Yu X; Thrift AP
    Aliment Pharmacol Ther; 2018 Aug; 48(4):469-477. PubMed ID: 29956826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for Barrett's oesophagus and oesophageal adenocarcinoma: results from the FINBAR study.
    Anderson LA; Watson RG; Murphy SJ; Johnston BT; Comber H; Mc Guigan J; Reynolds JV; Murray LJ
    World J Gastroenterol; 2007 Mar; 13(10):1585-94. PubMed ID: 17461453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic review with meta-analysis: prevalence of prior and concurrent Barrett's oesophagus in oesophageal adenocarcinoma patients.
    Tan MC; Mansour N; White DL; Sisson A; El-Serag HB; Thrift AP
    Aliment Pharmacol Ther; 2020 Jul; 52(1):20-36. PubMed ID: 32452599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NSAIDs, statins, low-dose aspirin and PPIs, and the risk of oesophageal adenocarcinoma among patients with Barrett's oesophagus: a population-based case-control study.
    Masclee GM; Coloma PM; Spaander MC; Kuipers EJ; Sturkenboom MC
    BMJ Open; 2015 Jan; 5(1):e006640. PubMed ID: 25633286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toenail trace element status and risk of Barrett's oesophagus and oesophageal adenocarcinoma: results from the FINBAR study.
    O'Rorke MA; Cantwell MM; Abnet CC; Brockman AJ; Murray LJ;
    Int J Cancer; 2012 Oct; 131(8):1882-91. PubMed ID: 22262413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of oesophageal cancer in Barrett's oesophagus and gastro-oesophageal reflux.
    Solaymani-Dodaran M; Logan RF; West J; Card T; Coupland C
    Gut; 2004 Aug; 53(8):1070-4. PubMed ID: 15247170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of oesophageal adenocarcinoma in individuals with Barrett's oesophagus.
    Holmberg D; Ness-Jensen E; Mattsson F; El-Serag HB; Lagergren J
    Eur J Cancer; 2017 Apr; 75():41-46. PubMed ID: 28214656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between Helicobacter pylori infection and gastric atrophy and the stages of the oesophageal inflammation, metaplasia, adenocarcinoma sequence: results from the FINBAR case-control study.
    Anderson LA; Murphy SJ; Johnston BT; Watson RG; Ferguson HR; Bamford KB; Ghazy A; McCarron P; McGuigan J; Reynolds JV; Comber H; Murray LJ
    Gut; 2008 Jun; 57(6):734-9. PubMed ID: 18025067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the magnitude of gastro-oesophageal reflux in Barrett's oesophagus.
    Parrilla P; Ortiz A; Martinez de Haro LF; Aguayo JL; Ramirez P
    Gut; 1990 Sep; 31(9):964-7. PubMed ID: 2210462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multivariate analysis of the association of acid and duodeno-gastro-oesophageal reflux exposure with the presence of oesophagitis, the severity of oesophagitis and Barrett's oesophagus.
    Koek GH; Sifrim D; Lerut T; Janssens J; Tack J
    Gut; 2008 Aug; 57(8):1056-64. PubMed ID: 18403496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Global prevalence of Barrett's oesophagus and oesophageal cancer in individuals with gastro-oesophageal reflux: a systematic review and meta-analysis.
    Eusebi LH; Cirota GG; Zagari RM; Ford AC
    Gut; 2021 Mar; 70(3):456-463. PubMed ID: 32732370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional single-nucleotide polymorphism of epidermal growth factor is associated with the development of Barrett's esophagus and esophageal adenocarcinoma.
    Menke V; Pot RG; Moons LM; van Zoest KP; Hansen B; van Dekken H; Siersema PD; Kusters JG; Kuipers EJ
    J Hum Genet; 2012 Jan; 57(1):26-32. PubMed ID: 22129558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of Barrett's oesophagus (clinical): LOS dysfunction, hiatal hernia, peristaltic defects.
    Roman S; Kahrilas PJ
    Best Pract Res Clin Gastroenterol; 2015 Feb; 29(1):17-28. PubMed ID: 25743453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.